Zhang Wenjiang | Department Of Applied Molecular Oncology Ontario Cancer Institute
スポンサーリンク
概要
関連著者
-
Zhang Wenjiang
Department Of Experimental Therapeutics Ontario Cancer Institute
-
Chen Eric
Department Of Applied Molecular Oncology Ontario Cancer Institute
-
Zhang Wenjiang
Department Of Applied Molecular Oncology Ontario Cancer Institute
-
MOORE Malcolm
Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University
-
Moore Malcolm
Department Of Experimental Therapeutics Ontario Cancer Institute
-
Zhang Wen
Department Of Chemistry East China Normal University
-
ZHANG Wenjiang
Department of Experimental Therapeutics, Ontario Cancer Institute, University Health Network
-
CHEN Eric
Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network
-
Zhang W
Dalian Inst. Chemical Physics Chinese Acad. Sci. Dalian Chn
-
Chen Eric
Department Of Medical Oncology And Hematology Princess Margaret Hospital
-
Zhang W
Department Of Chemistry East China Normal University
-
LEIGHL Natasha
Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network
-
ZAWISZA Diane
Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network
-
SIU Lillian
Department of Medical Oncology and Hematology, Princess Margaret Hospital
-
Siu Lillian
Department Of Medical Oncology And Hematology Princess Margaret Hospital
-
Zawisza Diane
Department Of Medical Oncology And Hematology Princess Margaret Hospital University Health Network
-
Leighl Natasha
Department Of Medical Oncology And Hematology Princess Margaret Hospital University Health Network
-
Seymour Lesley
Clinical Trial Group National Cancer Institute Of Canada
著作論文
- Determination of GTI-2040, a novel antisense oligonucleotide, in human plasma by using HPLC combined with solid phase and liquid-liquid extractions
- Simultaneous determination of OSI-774 and its major metabolite OSI-420 in human plasma by using HPLC with UV detection
- Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry